Logo for FT News podcast

Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an FT analysis. David Crow and Sujeet Indap discuss the findings.

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.